The Test That Could Save Women's Lives
Many women who had a raised risk of breast and ovarian cancer were not being tested for a gene that signifies a much higher cancer risk, a new study found.
FDA Approves First Rx for Rare Cancer
The first-ever treatment for a rare type of cancer has received approval from the US Food and Drug Administration (FDA).
Keytruda Gets a New Job
The US Food and Drug Administration (FDA) has granted accelerated approval to pembrolizumab (brand name Keytruda) for patients with classical Hodgkin lymphoma (cHL).
New Breast Cancer Rx Approved
The US Food and Drug Administration (FDA) has approved a new medication to treat breast cancer.
Sun Safety for Melanoma Survivors
Most melanoma survivors reported that they limited their sun exposure, but some said they got suntans and even sunburns, according to a new study.
Help for Carcinoid Syndrome Diarrhea
The US Food and Drug Administration (FDA) has approved a medication to treat diarrhea caused by rare tumors.
Keeping Breast Cancer from Coming Back
Physical activity may be the most important lifestyle choice in helping to keep breast cancer from coming back, according to a new study.
The Problem with False Positives
Women who receive a false positive result on a mammogram screening may be more likely to skip or delay their next screening, according to a new study. And that could put their health at risk.
Breast Cancer: The Effect of Side Effects
Around half of women undergoing treatment for early stage breast cancer reported severe side effects, according to a new study.
Men and HPV Vaccination
Despite human papillomavirus (HPV) vaccination programs becoming available to the public in 2009, vaccination rates among men remained relatively low, a new study found.